Zong Chuntao, Ran Xuebing
Department of Hematology, Xi'an Daxing Hospital, Xi'an, Shaanxi province, 710082, China.
Department of Clinical Laboratory, Meixian People's Hospital, Baoji City, 722300, China.
Heliyon. 2024 Aug 20;10(17):e36552. doi: 10.1016/j.heliyon.2024.e36552. eCollection 2024 Sep 15.
Chronic myeloid leukemia (CML) is a cancer in the bone marrow caused by the proliferation of granulocyte cells at all the maturation stages. Late diagnosis of CML decreases the patient survival rate, makes diagnosing CML is mandatory before entering the blastic phase. CD 19 is an important target for CML and is effectively utilized for therapeutic and diagnosis purposes. This research was focused on developing an aptamer-mediated circular interdigitated electrode (IDE) sensor for detecting the level of CD 19 and measured at 0-2 V with the step of 0.1 V. To improve the surface functionalization on IDE, the surface of IDE was modified with a single-walled carbon nanotube (SWCN) to enhance the aptamer immobilization. SWCN increased the aptamer attachment and also enhanced the analytical performances on IDE. This SWCN-aptamer modified IDE detected the CD 19 as low as 10 nM on a linear co-regression range from 10 to 100 nM [y = 2.0126x - 2.3857; R = 0.9749]. Furthermore, control performances with CD 33, and complementary aptamer did not show the increment of current, and CD 19 spiked human serum increased the current flow without significant interference, demonstrating the specific and selective detection of CD 19. This biosensor quantifies CD 19 biomarker at its lower level and diagnoses CML and its associated complications.
慢性粒细胞白血病(CML)是一种骨髓癌症,由所有成熟阶段的粒细胞增殖引起。CML的晚期诊断会降低患者生存率,因此在进入急变期之前确诊CML至关重要。CD 19是CML的一个重要靶点,可有效用于治疗和诊断目的。本研究专注于开发一种适体介导的圆形叉指电极(IDE)传感器,用于检测CD 19水平,并在0至2 V范围内以0.1 V的步长进行测量。为了改善IDE表面功能化,用单壁碳纳米管(SWCN)对IDE表面进行修饰,以增强适体固定。SWCN增加了适体附着,还提高了IDE的分析性能。这种SWCN - 适体修饰的IDE在线性回归范围为10至100 nM时,可检测低至10 nM的CD 19 [y = 2.0126x - 2.3857;R = 0.9749]。此外,用CD 33和互补适体进行的对照实验未显示电流增加,而加入CD 19的人血清增加了电流流动且无明显干扰,表明对CD 19具有特异性和选择性检测。这种生物传感器可在较低水平定量CD 19生物标志物,并诊断CML及其相关并发症。